Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Kereiakes

Showing results (1-10 of 143) with videos related to

Pageof 15
Sort By:
Clinical Cardiology|August 1, 1985
Myocardial infarction in the diabetic patientD J Kereiakes
Catheterization and Cardiovascular Diagnosis|July 1, 1996
Percutaneous transcatheter therapy of aorto-ostial stenosesD J Kereiakes
The Journal of Cardiovascular Management : the Official Journal of the American College of Cardiovascular Administrators|June 3, 1999
Into the third millennium: the changing face of cardiology practiceD J Kereiakes
American Heart Journal|July 1, 1999
Oral blockade of the platelet glycoprotein IIb/IIIa receptor: fact or fancy?D J Kereiakes
The American Journal of Cardiology|May 1, 1984
Effects of negative pleural pressure on left ventricular hemodynamicsD J Kereiakes
The American Journal of Cardiology|December 1, 1998
Dean James Kereiakes, MD: a conversation with the Editor. Interview by William Clifford RobertsD J Kereiakes
The American Journal of Cardiology|April 29, 1998
Preferential benefit of platelet glycoprotein IIb/IIIa receptor blockade: specific considerations by device and disease stateD J Kereiakes
Circulation|January 11, 2000
Attainment and maintenance of platelet inhibition through standard dosing of abciximab in patients undergoing percutaneous coronary interventionD J Kereiakes
The American Journal of Cardiology|February 19, 1998
Prophylactic platelet transfusion in abciximab-treated patients requiring emergency coronary bypass surgeryD J Kereiakes
Coronary Artery Disease|December 22, 1999
Oral platelet glycoprotein IIb/IIIa inhibitorsD J Kereiakes
Pageof 15

Showing results (1-10 of 143) with videos related to

Sort By:
Pageof 15
Clinical Cardiology|August 1, 1985
Myocardial infarction in the diabetic patientD J Kereiakes
Catheterization and Cardiovascular Diagnosis|July 1, 1996
Percutaneous transcatheter therapy of aorto-ostial stenosesD J Kereiakes
The Journal of Cardiovascular Management : the Official Journal of the American College of Cardiovascular Administrators|June 3, 1999
Into the third millennium: the changing face of cardiology practiceD J Kereiakes
American Heart Journal|July 1, 1999
Oral blockade of the platelet glycoprotein IIb/IIIa receptor: fact or fancy?D J Kereiakes
The American Journal of Cardiology|May 1, 1984
Effects of negative pleural pressure on left ventricular hemodynamicsD J Kereiakes
The American Journal of Cardiology|December 1, 1998
Dean James Kereiakes, MD: a conversation with the Editor. Interview by William Clifford RobertsD J Kereiakes
The American Journal of Cardiology|April 29, 1998
Preferential benefit of platelet glycoprotein IIb/IIIa receptor blockade: specific considerations by device and disease stateD J Kereiakes
Circulation|January 11, 2000
Attainment and maintenance of platelet inhibition through standard dosing of abciximab in patients undergoing percutaneous coronary interventionD J Kereiakes
The American Journal of Cardiology|February 19, 1998
Prophylactic platelet transfusion in abciximab-treated patients requiring emergency coronary bypass surgeryD J Kereiakes
Coronary Artery Disease|December 22, 1999
Oral platelet glycoprotein IIb/IIIa inhibitorsD J Kereiakes
Pageof 15